Fibroadenoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
==Risk Factors== | ==Risk Factors== | ||
* The table below lists the risk factors involved in the development of fibroadenoma: | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Risk Factor''' | |||
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Obesity'''|| style="padding: 5px 5px; background: #F5F5F5;" |An increase in BMI is correlated with an increased risk of fibroadenoma development. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Estrogen replacement therapy'''|| style="padding: 5px 5px; background: #F5F5F5;" |Estrogen replacement therapy is correlated with an increased risk of fibroadenoma development. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Pregnancy'''|| style="padding: 5px 5px; background: #F5F5F5;" |Nulliparous women are associated with an increased risk of fibroadenoma development. Whereas multiparous women are associated with a lower risk of fibroadenoma development. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Contraception'''|| style="padding: 5px 5px; background: #F5F5F5;" | The use of oral contraceptive pills is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Socioeconomic status'''|| style="padding: 5px 5px; background: #F5F5F5;" |A higher socioeconomic status is correlated with an increased risk of fibroadenoma development. | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:59, 1 February 2016
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma risk factors On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma risk factors |
|
Risk calculators and risk factors for Fibroadenoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Risk Factors
- The table below lists the risk factors involved in the development of fibroadenoma:
| Risk Factor | Description |
|---|---|
| Obesity | An increase in BMI is correlated with an increased risk of fibroadenoma development. |
| Estrogen replacement therapy | Estrogen replacement therapy is correlated with an increased risk of fibroadenoma development. |
| Pregnancy | Nulliparous women are associated with an increased risk of fibroadenoma development. Whereas multiparous women are associated with a lower risk of fibroadenoma development. |
| Contraception | The use of oral contraceptive pills is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods. |
| Socioeconomic status | A higher socioeconomic status is correlated with an increased risk of fibroadenoma development. |